Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.

A clinical study suggests metformin may reproduce part of exercise’s metabolic signature in prostate cancer patients, raising Lac-Phe levels while supporting better weight control during hormone ...

“By working across Sylvester’s Tumor Biology, Cancer Epigenetics and Translational & Clinical Oncology programs, we were able to link a well-defined molecular signal to real patient data. The result ...

Please provide your email address to receive an email when new articles are posted on . Men with prostate cancer who took metformin had increases in a metabolite that mirrored that seen with strenuous ...